QUE ONCOLOGY

QUE Oncology, Inc. (QUE) was formed through a collaboration between Emory University, in Atlanta, Georgia, and The University of Queensland (UQ) research commercialization company, UniQuest, in Brisbane, Australia. QUE licenses intellectual property originating from research discoveries at both UQ and Emory’s Institute for Drug Development (EIDD). The leading drug candidate is Q-122, a compound with anti-inflammatory properties that is in Phase 1b clinical development for the treatment of hot flashes in women with breast cancer who are receiving anti-estrogen therapy. Additional cancer research projects that have been identified to supply the QUE Oncology pipeline are designed to address prostate cancer, breast cancer, melanoma, and cancer pain.

#People #Financial #Website #More

QUE ONCOLOGY

Industry:

Biopharma Biotechnology Health Care Therapeutics

Founded:

2012-01-01

Address:

Melbourne, Victoria, Australia

Country:

Australia

Website Url:

http://www.queoncology.com

Total Employee:

11+

Status:

Active

Total Funding:

16.52 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Google Cloud

Current Employees Featured

wendy-painter_image

Wendy Painter
Wendy Painter Chief Medical Officer @ QUE Oncology
Chief Medical Officer

not_available_image

Alice Robertson
Alice Robertson Head of Clinical Operations @ QUE Oncology
Head of Clinical Operations

dennis-c-liotta_image

Dennis C. Liotta
Dennis C. Liotta Founder and Director @ QUE Oncology
Founder and Director

rob-crombie_image

Rob Crombie
Rob Crombie CEO @ QUE Oncology
CEO

Founder

dennis-c-liotta_image

Dennis C. Liotta

Investors List

uniseed-pty_image

Official Site Inspections

http://www.queoncology.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K

Host Informations
Whois Informations

Loading ...